OpenAlex
PricingAboutJobs
Log inGet started
Work

Copanlisib: First Global Approval

HTML

Year: 2017
Type: article
Source: Drugs
DOI: 10.1007/s40265-017-0838-6
Author: Anthony Markham
Language: English

Topic: Lymphoma Diagnosis and Treatment
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: copanlisib, PI3K inhibitors, relapsed follicular lymphoma, accelerated approval, diffuse large B-cell lymphoma, peripheral T-cell lymphoma, NK/T-cell lymphoma, cholangiocarcinoma, breast cancer, head and neck squamous cell carcinoma, PTEN loss, PIK3CA mutation, drug development, FDA approval
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2767661899
FWCI: 12.82
Cites: 13
Cited by: 195
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms